Convoke Secures $8.6M to Develop AI Operating System for Biopharma

Convoke Holdings, Inc. has raised $8.6 million in seed funding to develop its AI-native operating system for the biopharma industry, announced in a press release. The funding round was led by Kleiner Perkins and Dimension Capital, with participation from several other investors.

Convoke's platform is designed to transform raw data into actionable deliverables, helping drug developers accelerate the journey from concept to market. The system aims to reduce the time spent on manual and repetitive tasks by automating processes using language model-based systems. This approach is intended to increase efficiency and reduce the development cycle times for new drugs.

The platform serves as an "information factory" for biopharma knowledge work, enabling companies to ingest and structure data, build automations, and generate critical deliverables such as regulatory documents and competitive intelligence briefs. By automating these processes, Convoke allows biopharma teams to focus on strategic decision-making rather than manual workflows, potentially saving significant time and resources.